Cite
HARVARD Citation
Rustichelli, C. et al. (2020). Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review. Expert opinion on investigational drugs. pp. 1269-1275. [Online].